Doctors said, “The current trend is oral rheumatoid arthritis treatment”

“Needs of patients are pretty high for oral rheumatoid arthritis treatments. As long as the safety data of oral antirheumatic drugs is secured, there is a high chance for them to be a secondary rheumatoid arthritis treatment.”

As included as a secondary treatment option in the American College of Rheumatology(ACR) guideline, ‘Xeljanz(generic name: tofacitinib),’ the domestically first oral rhe...